clinical trial · NCT07287163
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Praxis Precision Medicines·phase3·enrolling by invitation·n = 700
Epilepsy, Tonic-ClonicFocal SeizurePrimary Generalized Seizurevormatrogine
brief summary
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
started
Oct 27, 2025
primary completion
May 31, 2028
completion
Dec 31, 2028
last updated
Dec 17, 2025
detailed description
An open label extension clinical trial to assess the safety and tolerability of vormatrigine in adults with focal or primary generalized tonic-clonic seizures.
official title
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol